| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/02/2023 | 15.55% | Goldman Sachs | $232 → $208 | Maintains | Neutral |
| 07/24/2023 | 8.33% | B of A Securities | → $195 | Downgrades | Neutral → Underperform |
| 07/21/2023 | 44.44% | JP Morgan | $238 → $260 | Maintains | Overweight |
| 07/21/2023 | 13.33% | Morgan Stanley | $190 → $204 | Maintains | Equal-Weight |
| 07/21/2023 | 32.77% | Baird | $260 → $239 | Maintains | Outperform |
| 07/21/2023 | 38.88% | Credit Suisse | $235 → $250 | Maintains | Outperform |
| 04/25/2023 | 38.88% | Needham | → $250 | Reiterates | → Buy |
| 04/21/2023 | 38.88% | Truist Securities | $260 → $250 | Maintains | Buy |
| 04/21/2023 | 13.88% | RBC Capital | → $205 | Reiterates | → Sector Perform |
| 04/21/2023 | 19.44% | Wells Fargo | $210 → $215 | Maintains | Equal-Weight |
| 04/21/2023 | 17.77% | Deutsche Bank | $214 → $212 | Maintains | Hold |
| 03/31/2023 | 30.55% | Barclays | $240 → $235 | Maintains | Overweight |
| 03/22/2023 | 5.55% | Morgan Stanley | $194 → $190 | Maintains | Equal-Weight |
| 02/10/2023 | 13.88% | RBC Capital | $185 → $205 | Maintains | Sector Perform |
| 02/10/2023 | 7.77% | Morgan Stanley | $197 → $194 | Maintains | Equal-Weight |
| 02/10/2023 | 31.66% | Baird | $223 → $237 | Maintains | Outperform |
| 02/10/2023 | 33.33% | Barclays | $230 → $240 | Maintains | Overweight |
| 02/06/2023 | 44.44% | Truist Securities | $195 → $260 | Maintains | Buy |
| 01/13/2023 | 16.66% | Wells Fargo | $165 → $210 | Maintains | Equal-Weight |
| 01/10/2023 | 17.77% | Goldman Sachs | $187 → $212 | Maintains | Neutral |
| 01/06/2023 | -16.67% | Exane BNP Paribas | → $150 | Initiates Coverage On | → Underperform |
| 01/04/2023 | 9.44% | Morgan Stanley | $192 → $197 | Maintains | Equal-Weight |
| 12/02/2022 | 27.77% | Barclays | $225 → $230 | Maintains | Overweight |
| 11/25/2022 | 23.88% | Baird | $199 → $223 | Maintains | Outperform |
| 11/18/2022 | 21.66% | JP Morgan | $196 → $219 | Maintains | Overweight |
| 11/15/2022 | 27.77% | Atlantic Equities | → $230 | Upgrades | Neutral → Overweight |
| 11/14/2022 | 27.77% | Needham | $190 → $230 | Maintains | Buy |
| 10/21/2022 | 6.66% | Morgan Stanley | $212 → $192 | Maintains | Equal-Weight |
| 10/21/2022 | -11.12% | Deutsche Bank | $185 → $160 | Maintains | Hold |
| 10/21/2022 | 3.88% | Goldman Sachs | $215 → $187 | Maintains | Neutral |
| 10/21/2022 | -8.34% | Wells Fargo | $200 → $165 | Maintains | Equal-Weight |
| 10/21/2022 | -12.23% | RBC Capital | $195 → $158 | Downgrades | Outperform → Sector Perform |
| 10/20/2022 | 5.55% | Needham | $250 → $190 | Maintains | Buy |
| 10/19/2022 | -10.56% | Jefferies | $250 → $161 | Downgrades | Buy → Hold |
| 10/18/2022 | 2.77% | Deutsche Bank | $221 → $185 | Maintains | Hold |
| 10/04/2022 | 24.99% | Barclays | $230 → $225 | Maintains | Overweight |
| 09/27/2022 | 17.77% | Morgan Stanley | $230 → $212 | Maintains | Equal-Weight |
| 09/22/2022 | 11.1% | Atlantic Equities | $225 → $200 | Maintains | Neutral |
| 08/16/2022 | 27.77% | Morgan Stanley | → $230 | Downgrades | Overweight → Equal-Weight |
| 08/15/2022 | 24.99% | Atlantic Equities | → $225 | Downgrades | Overweight → Neutral |
| 07/27/2022 | 27.77% | Barclays | $215 → $230 | Maintains | Overweight |
| 07/22/2022 | 27.77% | Truist Securities | $250 → $230 | Maintains | Buy |
| 07/22/2022 | 22.77% | Deutsche Bank | $223 → $221 | Maintains | Hold |
| 07/22/2022 | 27.77% | Morgan Stanley | $226 → $230 | Maintains | Overweight |
| 07/21/2022 | 36.1% | Credit Suisse | $250 → $245 | Maintains | Outperform |
| 07/20/2022 | 25.55% | Morgan Stanley | $227 → $226 | Maintains | Overweight |
| 07/13/2022 | 11.1% | Wells Fargo | → $200 | Initiates Coverage On | → Equal-Weight |
| 07/01/2022 | 23.88% | Stifel | $254 → $223 | Maintains | Buy |
| 06/17/2022 | 19.44% | Barclays | $250 → $215 | Maintains | Overweight |
| 06/16/2022 | 26.1% | Morgan Stanley | $250 → $227 | Maintains | Overweight |
| 04/22/2022 | 22.77% | Goldman Sachs | $255 → $221 | Maintains | Neutral |
| 04/22/2022 | 38.88% | Morgan Stanley | $274 → $250 | Maintains | Overweight |
| 04/22/2022 | 38.88% | Barclays | $300 → $250 | Maintains | Overweight |
| 04/22/2022 | 38.88% | Credit Suisse | $285 → $250 | Maintains | Outperform |
| 04/22/2022 | 24.99% | Deutsche Bank | $265 → $225 | Maintains | Hold |
| 04/22/2022 | 52.77% | Needham | $335 → $275 | Maintains | Buy |
| 04/21/2022 | 35.55% | RBC Capital | $300 → $244 | Maintains | Outperform |
| 04/21/2022 | — | Evercore ISI Group | Downgrades | Outperform → In-Line | |
| 03/30/2022 | 47.21% | Deutsche Bank | → $265 | Initiates Coverage On | → Hold |
| 03/17/2022 | 66.66% | Barclays | $330 → $300 | Maintains | Overweight |
| 03/16/2022 | 52.21% | Morgan Stanley | $296 → $274 | Maintains | Overweight |
| 02/11/2022 | 64.44% | Morgan Stanley | $325 → $296 | Maintains | Overweight |
| 01/31/2022 | 66.66% | RBC Capital | $294 → $300 | Upgrades | Sector Perform → Outperform |
| 01/27/2022 | 55.55% | Truist Securities | → $280 | Upgrades | Hold → Buy |
| 01/24/2022 | 56.1% | Baird | $290 → $281 | Upgrades | Neutral → Outperform |
| 01/05/2022 | 80.55% | Morgan Stanley | $264 → $325 | Upgrades | Equal-Weight → Overweight |
| 11/22/2021 | 61.1% | Exane BNP Paribas | → $290 | Downgrades | Outperform → Neutral |
| 11/12/2021 | 86.1% | Needham | $295 → $335 | Maintains | Buy |
| 11/11/2021 | 46.66% | Morgan Stanley | $255 → $264 | Maintains | Equal-Weight |
| 11/11/2021 | 63.32% | RBC Capital | $270 → $294 | Maintains | Sector Perform |
| 10/22/2021 | 58.32% | Argus Research | → $285 | Upgrades | Hold → Buy |
| 10/22/2021 | 41.66% | Morgan Stanley | $253 → $255 | Maintains | Equal-Weight |
| 10/14/2021 | 63.88% | Needham | $288 → $295 | Maintains | Buy |
| 09/23/2021 | 40.55% | Morgan Stanley | $241 → $253 | Maintains | Equal-Weight |
| 08/17/2021 | 83.32% | Barclays | $285 → $330 | Maintains | Overweight |
| 07/23/2021 | 33.88% | Morgan Stanley | $220 → $241 | Maintains | Equal-Weight |
| 07/22/2021 | 49.99% | RBC Capital | $259 → $270 | Maintains | Sector Perform |
| 07/22/2021 | 59.99% | Needham | $260 → $288 | Maintains | Buy |
| 07/08/2021 | 43.88% | RBC Capital | → $259 | Initiates Coverage On | → Sector Perform |
| 04/28/2021 | 49.99% | Barclays | $210 → $270 | Maintains | Overweight |
| 04/23/2021 | 22.22% | Morgan Stanley | $201 → $220 | Maintains | Equal-Weight |
| 04/22/2021 | 44.44% | Needham | $215 → $260 | Maintains | Buy |
| 02/11/2021 | 19.44% | Needham | $210 → $215 | Maintains | Buy |
| 01/06/2021 | 11.66% | Morgan Stanley | $184 → $201 | Maintains | Equal-Weight |
| 12/15/2020 | 26.66% | Atlantic Equities | → $228 | Upgrades | Neutral → Overweight |
| 12/11/2020 | 33.33% | Stifel | → $240 | Upgrades | Hold → Buy |
| 12/08/2020 | 16.66% | Needham | $200 → $210 | Maintains | Buy |
| 12/08/2020 | 16.66% | Barclays | $200 → $210 | Upgrades | Equal-Weight → Overweight |
| 10/20/2020 | 2.22% | Morgan Stanley | $190 → $184 | Maintains | Equal-Weight |
| 10/06/2020 | 11.1% | Needham | → $200 | Initiates Coverage On | → Buy |
| 09/09/2020 | 5.55% | Morgan Stanley | $178 → $190 | Maintains | Equal-Weight |
| 07/24/2020 | -0.01% | Stifel | $162 → $180 | Maintains | Hold |
| 07/24/2020 | -1.12% | Morgan Stanley | $163 → $178 | Maintains | Equal-Weight |
| 07/24/2020 | 11.1% | Barclays | $175 → $200 | Maintains | Equal-Weight |
| 07/10/2020 | -9.45% | Morgan Stanley | $153 → $163 | Maintains | Equal-Weight |
| 06/09/2020 | -15% | Morgan Stanley | $145 → $153 | Maintains | Equal-Weight |
| 06/09/2020 | -8.34% | SunTrust Robinson Humphrey | → $165 | Downgrades | Buy → Hold |
| 06/03/2020 | -2.78% | Credit Suisse | $142 → $175 | Maintains | Outperform |
| 06/03/2020 | -19.45% | Morgan Stanley | $133 → $145 | Maintains | Equal-Weight |
| 05/15/2020 | -16.12% | Atlantic Equities | → $151 | Downgrades | Overweight → Neutral |
| 04/22/2020 | -26.12% | Morgan Stanley | $128 → $133 | Maintains | Equal-Weight |
| 04/21/2020 | -21.67% | CFRA | $173 → $141 | Maintains | Hold |
| 04/16/2020 | -16.67% | SunTrust Robinson Humphrey | $185 → $150 | Maintains | Buy |
| 04/14/2020 | -28.89% | Morgan Stanley | $150 → $128 | Maintains | Equal-Weight |
| 04/09/2020 | -38.89% | Barclays | $140 → $110 | Maintains | Equal-Weight |
| 04/06/2020 | — | Argus Research | Downgrades | Buy → Hold | |
| 02/18/2020 | -12.78% | Deutsche Bank | $148 → $157 | Maintains | Hold |
| 02/18/2020 | -10% | Stifel | $136 → $162 | Maintains | Hold |
| 02/14/2020 | -16.67% | Morgan Stanley | $140 → $150 | Maintains | Equal-Weight |
| 01/17/2020 | — | Argus Research | Upgrades | Hold → Buy | |
| 11/22/2019 | — | Jefferies | Initiates Coverage On | → Buy | |
| 10/25/2019 | -12.78% | Credit Suisse | $150 → $157 | Maintains | Outperform |
| 10/10/2019 | -27.23% | Morgan Stanley | $129 → $131 | Maintains | Equal-Weight |
| 10/02/2019 | -27.78% | B of A Securities | $122 → $130 | Maintains | Underperform |
| 07/26/2019 | -15% | Baird | $129 → $153 | Maintains | Outperform |
| 07/26/2019 | -27.23% | Stephens & Co. | $130 → $131 | Maintains | Equal-Weight |
| 07/19/2019 | -28.34% | Morgan Stanley | $115 → $129 | Maintains | Equal-Weight |
| 07/02/2019 | -24.45% | Deutsche Bank | $110 → $136 | Maintains | Hold |
| 02/05/2019 | — | Deutsche Bank | Downgrades | Buy → Hold | |
| 01/14/2019 | -38.89% | Deutsche Bank | $128 → $110 | Maintains | Buy |
| 01/08/2019 | -42.23% | Morgan Stanley | $115 → $104 | Maintains | Equal-Weight |
| 12/19/2018 | -39.45% | Baird | $115 → $109 | Maintains | Outperform |
| 12/07/2018 | -30.56% | Credit Suisse | → $125 | Initiates Coverage On | → Outperform |
| 10/26/2018 | -23.89% | Wells Fargo | $145 → $137 | Maintains | Outperform |
| 10/26/2018 | -41.67% | Barclays | $120 → $105 | Maintains | Equal-Weight |
| 10/25/2018 | -36.11% | Morgan Stanley | $126 → $115 | Maintains | Equal-Weight |
| 10/23/2018 | -31.67% | B of A Securities | → $123 | Reinstates | → Underperform |
| 10/15/2018 | -30% | Morgan Stanley | $127 → $126 | Maintains | Equal-Weight |
What is the target price for Equifax (EFX)?
The latest price target for Equifax (NYSE: EFX) was reported by Goldman Sachs on October 2, 2023. The analyst firm set a price target for $208.00 expecting EFX to rise to within 12 months (a possible 15.55% upside). 35 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Equifax (EFX)?
The latest analyst rating for Equifax (NYSE: EFX) was provided by Goldman Sachs, and Equifax maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Equifax (EFX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Equifax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Equifax was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.
Is the Analyst Rating Equifax (EFX) correct?
While ratings are subjective and will change, the latest Equifax (EFX) rating was a maintained with a price target of $232.00 to $208.00. The current price Equifax (EFX) is trading at is $180.01, which is out of the analyst's predicted range.